Top compounds associated with response to EEFSEC


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC 0.008 0.8
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA Nilotinib CCLE pan-cancer AAC 0.011 0.8
mRNA hyperforin CTRPv2 pan-cancer AAC 0.0083 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0069 0.8
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.007 0.8
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.007 0.8
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.0071 0.8
Download CSV